- Home
- QLGN vs AQB Comparison
QLGN vs AQB Comparison
Compare QLGN & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- AQB
- Stock Information
- Founded
- QLGN 1996
- AQB 1991
- Country
- QLGN United States
- AQB United States
- Employees
- QLGN N/A
- AQB N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- AQB
- Sector
- QLGN Health Care
- AQB
- Exchange
- QLGN Nasdaq
- AQB Nasdaq
- Market Cap
- QLGN 2.8M
- AQB 2.9M
- IPO Year
- QLGN N/A
- AQB N/A
- Fundamental
- Price
- QLGN $3.54
- AQB $0.74
- Analyst Decision
- QLGN
- AQB
- Analyst Count
- QLGN 0
- AQB 0
- Target Price
- QLGN N/A
- AQB N/A
- AVG Volume (30 Days)
- QLGN 9.1K
- AQB 217.2K
- Earning Date
- QLGN 08-13-2025
- AQB 08-05-2025
- Dividend Yield
- QLGN N/A
- AQB N/A
- EPS Growth
- QLGN N/A
- AQB N/A
- EPS
- QLGN N/A
- AQB N/A
- Revenue
- QLGN N/A
- AQB N/A
- Revenue This Year
- QLGN N/A
- AQB N/A
- Revenue Next Year
- QLGN N/A
- AQB N/A
- P/E Ratio
- QLGN N/A
- AQB N/A
- Revenue Growth
- QLGN N/A
- AQB N/A
- 52 Week Low
- QLGN $2.85
- AQB $0.47
- 52 Week High
- QLGN $29.44
- AQB $1.94
- Technical
- Relative Strength Index (RSI)
- QLGN 44.87
- AQB 43.79
- Support Level
- QLGN $3.37
- AQB $0.75
- Resistance Level
- QLGN $3.85
- AQB $0.85
- Average True Range (ATR)
- QLGN 0.23
- AQB 0.08
- MACD
- QLGN -0.03
- AQB -0.01
- Stochastic Oscillator
- QLGN 34.29
- AQB 14.46
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.